Beaten down Valeant Pharma (NYSE: VRX) is adding to yesterday's gains in pre-open trade ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trader Talk

Valeant (VRX) PT, Estimates Cut at BMO Capital; Remains on the SidelinesNovember 3, 2015 8:18 AM Philidor to Cease Operations (VRX) November 3, 2015 6:26 AM Bill Ackman's Pershing Square Down 19% YTD (VRX)November 2, 2015 9:27 PM Valeant Pharma (VRX) Issues Dear Doctor Letter; Philidor Issues Release - Evercore ISINovember 2, 2015 9:04 PM Market Wrap: Dow Jones Turns Positive for 2015; Citron Out with More on Valeant; Mergers GaloreNovember 2, 2015 5:44 PM Dead Cat Bounce, Or is a Sustainable Relief Rally in Store for Valeant (VRX)?November 2, 2015 3:17 PM Valeant Pharma (VRX) Was Top Stock for TD Ameritrade Retail Clients on Friday - SherrodNovember 2, 2015 2:03 PM Goldman Sachs says Valeant has long road ahead, cuts ratingNovember 2, 2015 1:19 PM Citron's Andrew Left said he is not done with Valeant (VRX) story; Will pass info to main stream mediaNovember 2, 2015 12:28 PM Citron's Andrew Left denies he made $150 million short Valeant (VRX)November 2, 2015 12:25 PM Citron's Left stands by story on Valeant (VRX)November 2, 2015 12:25 PM